Differential effects of gestational buprenorphine, naloxone, and methadone on mesolimbic μ opioid and ORL1 receptor G protein coupling
- 19 July 2004
- journal article
- research article
- Published by Elsevier BV in Developmental Brain Research
- Vol. 151 (1-2), 149-157
- https://doi.org/10.1016/j.devbrainres.2004.05.002
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Opioid Agonists Have Different Efficacy Profiles for G Protein Activation, Rapid Desensitization, and Endocytosis of Mu-opioid ReceptorsPublished by Elsevier BV ,2003
- Role of Steroids in Sex Differences in Morphine-Induced Analgesia: Activational and Organizational EffectsThe Journal of pharmacology and experimental therapeutics, 2002
- Treatment of Heroin (Diamorphine) AddictionDrugs, 2002
- Agonistic effects of the opioid buprenorphine on the nociceptin/OFQ receptorPeptides, 2000
- Brain opioid receptor adaptation and expression after prenatal exposure to buprenorphineDevelopmental Brain Research, 1998
- Prenatal Buprenorphine Exposure and Sexually Dimorphic Nonreproductive Behaviors in RatsPharmacology Biochemistry and Behavior, 1997
- Transient down-regulation of neonatal rat brain μ-opioid receptors upon in utero exposure to buprenorphineDevelopmental Brain Research, 1994
- Up-regulation of opiate receptors by opiate antagonists in neuroblastoma-glioma cell culture: The possibility of interaction with guanosine triphosphate-binding proteinsNeuroscience Letters, 1984
- Fetal Exposure to Narcotics: Neonatal Sleep as a Measure of Nervous System DisturbanceScience, 1980
- AGONIST AND ANTAGONIST PROPERTIES OF BUPRENORPHINE, A NEW ANTINOCICEPTIVE AGENTBritish Journal of Pharmacology, 1977